SEP 16, 2016 06:26 AM PDT

TSRI Study Suggests Disordered Protein 'Shape Shifts' to Avoid Crowding

How does a cell's crowded environment impact protein behavior? Scientists work to find out.

LA JOLLA, CA – September 16, 2016 – Scientists at The Scripps Research Institute (TSRI) have brought physics and biology together to further understand how cells’ crowded surfaces induce complex protein behavior.

Their findings suggest that a disordered protein, called alpha-synuclein, partially escapes from the cell membrane when it runs out of space.
The Scripps Research Institute's Ashok Deniz, Mahdi Muhammad Moosa and Priya Banerjee (left to right) were authors of the new study, which was designated as a "hot paper" by Angewandte Chemie.

“This study provides new insight into the complex structural physics of three-component protein interactions in biology,” said TSRI Associate Professor Ashok Deniz, who led the new study, which was designated as a “hot paper” by the journal Angewandte Chemie.

A Crowded Neighborhood

Cells are crowded places, and many biophysicists have studied the effects of such crowding on the structural features of biological molecules, such as proteins. These studies tend to be done in three dimensions, with proteins suspended in a dilute solution and crowded from all sides. The new research brought scientists closer to understanding how crowding on the two-dimensional surface of a cell membrane can influence protein biophysics and function.

“This issue is particularly important given that interactions of some disordered proteins with membranes are critical elements of cellular function and health,” said Deniz.

The team focused on alpha-synuclein because it is an important example of an “intrinsically disordered protein” (IDP), which means it has relatively little structure on its own. Like several other IDPs, it can change its shape depending on interactions with nearby partners. The flexibility of IDPs makes it hard for scientists to capture clear images of them in action. Alpha-synuclein has also been linked to Parkinson’s disease, making it an interesting target for understanding the roles of IDPs in disease.

In the new study, the scientists investigated how alpha-synuclein behaves when the membrane is crowded by a second protein, called Hsp27. By adding this third component to the alpha-synuclein-membrane scene, the scientists came closer to seeing what really happens in a complex cell membrane environment, where real estate is naturally limited.

The researchers found a surprising change in the alpha-synuclein shape when it gets crowded by Hsp27. “The protein is staying partially bound, but our data suggest that part of it is flipping off the surface,” said Deniz.

The scientists said the work combined experiments, observations and simulations, which together pointed toward an explanation of the findings in terms of relatively simple physics.

Finding New Partners

The scientists think the section that detaches from the surface might work as an “arm” for waving down new potential partners.

“The fragment of alpha-synuclein can potentially interact with other binding partners, which could initiate further function,” said TSRI Graduate Student Mahdi Muhammad Moosa, who served as first author of the study with TSRI Research Associate Priya R. Banerjee.

The scientists added that other intrinsically disordered proteins may have similar reactions to crowding on membranes by proteins other than Hsp27. “We think the basic features of this model, in principle, could be applied to any intrinsically disordered protein that is bound to the cell membrane,” said Banerjee.

The researchers said the next step in this research will be to study how cell membrane composition and other modifications might alter how crowded membranes modulate the shape and cellular function of intrinsically disordered proteins.

The study, “Two-dimensional crowding uncovers a hidden conformation of α-synuclein,” was supported by the National Institutes of Health’s National Institute of General Medical Sciences (grant RO1 GM066833) and a postdoctoral fellowship from the American Heart Association (grant 15POST22520013).

This article was originally published on
About the Author
  • The Scripps Research Institute (TSRI) is one of the world's largest independent, not-for-profit organizations focusing on research in the biomedical sciences. TSRI is internationally recognized for its contributions to science and health, including its role in laying the foundation for new treatments for cancer, rheumatoid arthritis, hemophilia, and other diseases. An institution that evolved from the Scripps Metabolic Clinic founded by philanthropist Ellen Browning Scripps in 1924, the institute now employs about 2,700 people on its campuses in La Jolla, CA, and Jupiter, FL, where its renowned scientists-including two Nobel laureates-work toward their next discoveries. The institute's graduate program, which awards PhD degrees in biology and chemistry, ranks among the top ten of its kind in the nation. For more information, see
You May Also Like
OCT 20, 2019
Genetics & Genomics
OCT 20, 2019
Altering Dozens or Hundreds of Genes at Once
Since it was developed, the CRISPR gene editing system has been refined and advanced....
OCT 20, 2019
OCT 20, 2019
Bioprinting Complex Tissues
Tissue engineering is a quickly growing field that involves the development of artificial organs and tissues that can be utilized to test the efficacy of d...
OCT 20, 2019
Drug Discovery & Development
OCT 20, 2019
The Three Drugs that Reverse Biological Aging
In the last 100 years, life expectancy in the US has risen from 55 years until 79 (Roser: 2019). And with the continuous development of medicine and scie...
OCT 20, 2019
OCT 20, 2019
Bacterial Enzyme Strips Inflammatory Carbohydrate From Meat
Humans don't make a carbohydrate called Neu5Gc, but most mammals, including cows, do....
OCT 20, 2019
Cell & Molecular Biology
OCT 20, 2019
During REM Sleep, the Brain Can Intentionally Forget
As we sleep, our bodies cycle through several stages. One is the REM or rapid eye movement stage, during which most dreams occur....
OCT 20, 2019
Cell & Molecular Biology
OCT 20, 2019
Differences in Pediatric vs. Adult Cancer Force the Discussion of Effective Therapies
A team of scientists study the differences between childhood and adult cancer. This drives the discussion of the use of effective adult cancer treatments on children....
Loading Comments...